Living in today’s modern society illness seems to be running rampant. Cancer in particular, has seemed to touch most of our lives in one way or another and it is one of the most common diseases in the world as of today. The good thing about this is that there are some very good cancer fighting drugs on the market and in production. There is one company in particular that is leading the way among it’s contemporaries and setting new beneficial trends in this huge pharmaceutical market.Seattle Genetics, located in the great State of Washington, is transcending the game with it’s revolutionary cancer fighting drugs and it’s (CEO) Clay Siegall is leading the charge.
Dr. Clay Siegall co-founded the company back in 1998 and is now it’s current President and CEO. Dr. Siegall has a strong passion in what he does and his commitment to helping others is surely evident. This George Washington University Graduate has a Ph.D in Genetics and a prestige B.S. in Zoology from the University of Maryland. Seattle Genetics has become known as the leader in (ADC) Antibody Drug Conjugates thanks to the effectiveness of these cell-killing agents. The company has one of the most popular and successful drugs known as(Brentuximabvedotin)and it is commercially available in over 60 countries worldwide. Dr. Siegall’s vision can’t be denied since he is the heart and soul of the entire organization.
The good doctor’s huge resume of accomplishments can’t be understated as he is the author of well over 70 publications, Entrepreneur of the year, and he currently holds up to 15 patents. The fight against cancer is underway and is certainly getting stronger thanks to Dr. Clay Siegall and his prominent company Seattle Genetics.